Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET Imaging of Tau Pathology in Neurodegenerative Disease
NCT03143374Phase 3Recruiting
- Sponsor
- University of Pennsylvania
- Start
- Aug 2016
- Primary completion
- Sep 2030
- Countries
- 1
01
Overview
A Phase 3 trial of flortaucipir in neurodegenerative disease, sponsored by University of Pennsylvania. Started Aug 2016; status: recruiting.
02
Drugs
flortaucipir
03
Conditions
neurodegenerative disease
Beyond the preview
Go deeper on NCT03143374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03143374.